期刊文献+

细胞色素P450 2E1在利福平减弱异烟肼引起肝脏发生氧化应激中的作用 被引量:1

The role of cytochrome P450 2E1 on rifampicin attenuating the isoniaizid-induced oxidative stress in liver
下载PDF
导出
摘要 目的研究利福平(RIF)减弱异烟肼(INH)引起小鼠肝脏发生氧化应激的作用机制。方法将♀ICR成年健康小鼠随机分为4组:50mg/kgINH组;100mg/kgRIF组;INH+RIF组:同时给予INH(50mg/kg)和RIF(100mg/kg);对照组:给予等容量的溶剂,所有小鼠每日均给予处理1次,连续处理1周。分析血清中谷丙转氨酶(ALT)、谷草转氨酶(AST)、碱性磷酸酶(AKP)、总胆红素(TB)和总胆汁酸(TBA)水平,Griffith法测定肝脏组织谷胱甘肽(GSH)含量,TBARS比色法分析肝脏组织脂质过氧化水平,RT-PCR技术检测肝脏组织细胞色素P4502E1(CYP2E1)mRNA水平,Westernblot检测肝脏组织CYP2E1蛋白表达水平。结果 INH、RIF及RIF与INH共处理组小鼠血清中ALT均轻度升高,INH处理显著升高肝脏组织脂质过氧化水平并降低GSH含量,RIF共处理显著减弱INH升高肝脏组织脂质过氧化水平并降低GSH含量。单纯RIF处理显著下调肝脏组织CYP2E1蛋白表达水平,且RIF共处理显著减弱INH对肝脏组织CYP2E1蛋白表达的诱导作用;所有处理对CYP2E1mRNA水平无明显影响。结论 RIF减弱INH引起肝脏组织发生氧化应激中,CYP2E1发挥了一定作用。 Objective To investigate the mechanism of rifampicin attenuate the isoniaizid-induced oxidative stress in mouse liver. Methods Animals received anti-TB drugs,rifampicin and isoniaizid-alone or in combination-once daily for up to one week. Assays for alanine aminotransferase(ALT) ,alkaline phosphatase(ALP) were performed to assess liver toxicity. The GSH content in liver was determined by the method of Griffith and lipid peroxidation was quantified by measuring malondialdehyde(MDA) . The expressions of CYP 2E1 in liver were determined by Western blotting. Results Compared with the animals received INH alone,the group received rifampicin and isoniaizid in combination produced a progressive enhancement in glutathione (GSH) and a descendent in malondialdehyde (MDA) ,and there was no significant difference between the group received RIF alone and the group for contrast. RIF significantly reduced the expression of CYP 2E1 in mouse liver. Conclusion RIF can attenuate the INH induced oxidative hepatic injury via reduce the expression of CYP 2E1 and cause imbalance in endogenous enzymatic oxidant-antioxidant defense.
出处 《安徽医科大学学报》 CAS 北大核心 2010年第5期609-613,共5页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:30973544) 安徽省自然科学基金(编号:090413142)
关键词 利福平 异烟肼 氧化性应激 肝病/病理生理学 细胞色素P450 CYP 2E1 rifampin isoniazid oxidative stress liver diseases/physiopathology cytochrome P450 CYP 2E1
  • 相关文献

参考文献2

二级参考文献18

  • 1RavinderPal,ArbabSikander,KartarSingh,SatyaVRana,Kim Vaiphei.Effect of garlic on isoniazid and rifampicin-induced hepatic injury in rats[J].World Journal of Gastroenterology,2006,12(4):636-639. 被引量:23
  • 2查月芳,曾文,胡建军,张广宇,李欣,袁志芳,佟晓旭.主要抗结核药物肝脏毒性的动物实验研究[J].中国防痨杂志,2006,28(3):174-177. 被引量:35
  • 3Huang R, Okuno H, Takasu M, Shiozaki Y, Inoue K. Protective effect of rifampicin against acute liver injury induced by carbon tetrachloride in mice. Jpn J Pharmacol 1995; 69: 325-34.
  • 4Takeda K, Watanabe J, Inoue K, Kanamura S. Rifampicin suppresses hepatic CYP2E 1 expression and minimizes DNA injury caused by carbon tetrachloride in periventricular hepatocytes of mice. Alcohol Clin Exp Res 2000; 24 (4 Suppl):87-92.
  • 5Morel G, Cossec B, Lambert AM, Binet S. Evaluation of rat hepatic 2El activity in function of age, sex and inducers:choice of an experimental model capable of testing the hepatotoxicity of low molecular weight compounds. Toxicol Lett 1999; 106: 171-80.
  • 6Peng RX, Lei SB, Gao P. The capacity of drug metabolism in Chinese fetal livers: II. Metabolism of ethylmorphine, aminopyrine and aniline. Asian Pac J Pharmacol 1990; 5: 13-8.
  • 7Lowry OH, Rosebrough NJ, Parr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
  • 8Sarich TC, Adams SP, Petricca G, Wright JM. Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreat mentwith an amidase inhibitor. J Pharmacol Exp Ther 1999; 289:695-702.
  • 9Morris DL, Davila JC. Analysis of rat cytochrome P450 isoenzyme expression using semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Biochem Pharmacol 1996; 52: 781-92.
  • 10Powell H, Kitteringham NR, Pirmonhamed M, Smith DA,Park BK. Expression of cytochrome P4502EI in human liver: assessment by mRNA, genotype and phenotype. Pharmacogenetics 1998; 8: 411-21.

共引文献37

同被引文献32

  • 1No authors listed. Crunch time for tuberculosis control[ J].Lancet, 2009, 373: 1145.
  • 2FRIEDEN T R,STERLING T R,MUNSIFF S S,et al. Tuber-culosis [J]. Lancet,2003,362:887-899.
  • 3GIRLING D J. The hepatic toxicity of antituberculosis regimenscontaining isoniazid,rifampicin and pyrazinamide[ J]. Tuber-cle,1978,59:13-32.
  • 4SHARIFZADEH M,RASOULINEJAD M,VALIPOUR F,et al.Evaluation of patient-related factors associated with causality,preventability,predictability and severity of hepatotoxicity dur-ing antituberculosis f correction of antituberclosis ] treatment[J]. Pharmacol Res,2005 ,51:353-358.
  • 5with isoniazid and rifampin. Ameta- analysis [ J ] . Chest, 1991,99:465-471.
  • 6BENICHOU C. Criteria of drug-induced liver disorders. Reportof an international consensus meeting [ J]. J Hepatol, 1990,11:272-276.
  • 7FOUNTAIN F F,TOLLEY E, CHRISM AN C R,et al. Isoniazidhepatotoxicity associated with treatment of latent tuberculosis,infection : a 7-year evaluation from a public health tuberculosisclinic [J]. Chest ,2005,128:116-123.
  • 8SARICH T C,YOUSSEFI M,ZHOU T,et al. Role of hydrazinein the mechanism of isoniazid hepatotoxicity in rabbits [ J ].Arch Toxicol,1996,70:835-840.
  • 9SARICH T C,ZHOU T,ADAMS S P,et al. A model of isonia-. zid-induced hepatotoxicity in rabbits [ J ]. J Pharmacol ToxicolMethods, 1995 ,34:109-116.
  • 10MITCHELL J R,ZIMMERMAN H J,ISHAK KG,et al. Isoni-azid liver injury: clinical spectrum, pathology, and probablepathogenesis[ J]. Ann Intetn Med,1976,84:181.

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部